Last week, Benzinga’s Psychedelics Capital Conference brought a premier gathering of the biggest publicly traded psychedelics companies in North America with forward-thinking investors to Miami, where the hottest topic seemed to revolve around LSD and derivative molecules.
Having spent the majority of my life dealing with severe anxiety disorder, I have only recently shifted my thinking away from “what pills” can I take to push it down to conversations about what forms of treatment and studies have been done that could help me navigate the almost defeating waters of my own mind I experience everyday, from the moment I wake up each morning.
